β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

Vancomycin (VAN) is often used to treat methicillin-resistant Staphylococcus aureus (MRSA) bacteremia despite a high incidence of microbiological failure. Recent in vitro analyses of β-lactams in combination with VAN demonstrated synergistic activity against MRSA. The goal of this study was to exami...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dilworth, Thomas J., Ibrahim, Omar, Hall, Pamela, Sliwinski, Jora, Walraven, Carla, Mercier, Renée-Claude
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2014
Materias:
Clinical Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910806/
https://ncbi.nlm.nih.gov/pubmed/24145519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01204-13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares